Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Metabolic Explorer currently has 1 pending office action. This prosecution activity is located within the Biotechnology & Pharmaceuticals technology area. The 1 pending office action represents the current focus of the company's patent prosecution efforts.
The data identifies 1 distinct examiner and 1 distinct art unit for this portfolio. This concentration within 1 distinct art unit suggests that the technical review is being handled by a specialized group familiar with Biotechnology & Pharmaceuticals. IANNUZO, NATALIE NMN is the busiest examiner assigned to the company's matters and is responsible for 1 pending office action.
The prosecution strategy for this 1 pending office action is directly tied to the individual review style of IANNUZO, NATALIE NMN. Because there is 1 distinct examiner involved, the company does not have to manage conflicting requirements from different officials. This relationship between the examiner and the 1 pending office action allows for a concentrated effort to address the specific concerns raised in the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IANNUZO, NATALIE NMN | 1 | 12.5% | +71.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797907 | MODIFIED MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF ECTOINE | IANNUZO, NATALIE NMN | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797907 | MODIFIED MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF ECTOINE | IANNUZO, NATALIE NMN | 12d |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17797907 | MODIFIED MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF ECTOINE | IANNUZO, NATALIE NMN | 1653 | §103§112 | Final Rejection | 12d | Pending | Aug 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial